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Abstract
Background
Dengue-related illness is a leading cause of hospitalization and death in Thailand and other
Southeast Asian countries, imposing a major economic burden on households, health sys-
tems, and governments. This study aims to assess the economic impact of hospitalized
dengue cases on households in Chachoengsao province in eastern Thailand.
Methods
We conducted a prospective cost-of-illness study of hospitalized pediatric and adult dengue
patients at three public hospitals. We examined all hospitalized dengue cases regardless of
disease severity. Patients or their legal guardians were interviewed using a standard ques-
tionnaire to determine household-level medical and non-medical expenditures and income
losses during the illness episode.
Results
Between March and September 2015, we recruited a total of 224 hospitalized patients (<5
years, 4%; 5–14 years, 20%, 15–24 years, 36%, 25–34 years, 15%; 35–44 years, 10%; 45+
years, 12%), who were clinically diagnosed with dengue. The total cost of a hospitalized
dengue case was higher for adult patients than pediatric patients, and was US$153.6 and
US$166.3 for pediatric DF and DHF patients, respectively, and US$171.2 and US$226.1 for
adult DF and DHF patients, respectively. The financial burden on households increased
with the severity of dengue illness.
Conclusions
Although 74% of the households reported that the patient received free medical care, hospi-
talized dengue illness cost approximately 19–23% of the monthly household income. These
results indicated that dengue imposed a substantial financial burden on households in
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Thailand where a great majority of the population was covered by the Universal Coverage
Scheme for health care.
Author summary
Dengue, an arbovirus infection with an explosive epidemic potential, is a major public
health problem in Thailand and other developing countries in subtropical and tropical
regions. Dengue illness often leads to school and work absenteeism, medical and non-
medical expenditures, and foregone income. A growing literature shows that these illness
related costs pose a severe economic burden on households, health care systems, and gov-
ernments. We conducted a prospective cost-of-illness study to assess the costs and impact
of hospitalized pediatric and adult dengue cases on households in a highly endemic area
in eastern Thailand. We found that the total cost of a hospitalized dengue case accounted
for about 19–23% the monthly household income. Although direct medical costs were
covered for a majority of hospitalized dengue patients by the Thai Universal Coverage
Scheme for health care, direct non-medical and indirect costs were of great economic sig-
nificance to households. These hidden costs of dengue illness are likely to increase given
the shift in the mean age of dengue cases in Thailand and other endemic countries in the
region. High household costs of dengue illness justify efforts to improve the coverage of
preventive and control measures against dengue in endemic areas.
Introduction
Dengue, an arbovirus infection with an explosive epidemic potential, is a major public health
problem in many tropical and subtropical countries today [1]. The incidence of dengue has
dramatically increased over the past decades, with the number of symptomatic dengue infec-
tions reported to be doubling every 10 years between 1990 and 2013 [2]. Dengue hemorrhagic
fever (DHF), a severe and potentially life-threatening form of the disease, has also reported to
be increasing steadily during this period, driving the increase in hospitalization rates for den-
gue, particularly in children [3–7]. Yet, an increasing number of studies have shown that there
is substantial under-reporting of dengue cases to national surveillance systems, which prevents
an accurate estimation of the disease burden of dengue in endemic countries [8]. Despite its
limited effectiveness and high cost, vector control is the mainstay of dengue control and out-
break response in endemic areas [9–12]. The disease is expected to further expand its geo-
graphical range due to favorable conditions provided by rapidly growing high density urban
areas along with socio-economic changes [13], increased worldwide travel and trade [14], and
climate change [15]. A growing literature shows that dengue imposes an enormous socioeco-
nomic burden on households, health care systems, and governments in endemic countries
[16–18], particularly during outbreaks [19–22].
Reported as a public health problem since the 1950s, dengue causes frequent outbreaks in
Thailand and is hyperendemic with all four distinct serotypes of the dengue virus in circulation
for more than five decades [23]. Although dengue has traditionally affected children, there has
been a shift in the mean age of dengue cases towards older age groups in Thailand and other
dengue hyperendemic countries in Southeast Asia [24–28]. Most dengue cases now occur in
individuals aged 5–24 years [29], which account for one third of the total population in Thailand,
and the disease is more common in adolescents and young adults [30]. The incidence of DHF
varies widely from year to year, exhibiting as much as a tenfold difference between years [26].
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During the period 2000–2011, the incidence of DHF was higher in children aged 5–14 years
than those aged 15 years or older [29]. While the case fatality rate of dengue has been declining
steadily over the past decade, the highest rates are seen in children aged 0–4 years [29].
Frequent and severe illness can cause considerable social and economic disruption to
households by requiring one or multiple visits to health care providers and hospitalization.
Dengue illness often leads to school and work absenteeism, medical and non-medical expendi-
tures, and foregone income. Illness related costs incurred by patients and household members
constitute a severe economic burden for households, particularly in developing country set-
tings. To accurately assess the overall economic burden of dengue, cost-of-illness data at the
household level are, therefore, essential. Within the context of a European Union funded
research project on dengue [31], we conducted a prospective hospital-based cost-of-illness
study to assess the cost and impact of hospitalized dengue cases on households in a highly
endemic area in eastern Thailand. Previous cost-of-illness studies in Thailand focused primar-
ily on pediatric dengue patients (aged under 15 years) [32–36]. In view of the shift in the age
distribution of dengue cases, we expanded the focus to cover adult dengue patients (aged 15
years and above).
Material and methods
Study design
We conducted a prospective, hospital-based cost-of-illness study in Chacheongsao province in
eastern Thailand. Chachoengsao is a highly endemic area for dengue with a population of
700,902 in 2015 [37] and a surface area of 5,351 km2. The province is divided into 11 districts
with 93 sub-districts, and has one province-level and nine district-level hospitals in total. His-
torically an agriculture-based province with rice paddies, fruit plantations, and livestock, it has
become industrialized in recent years, transitioning from rural to semi-rural and semi-rural to
semi-urban.
One provincial-level and two district-level public hospitals participated in the study. The
study population included hospitalized pediatric (aged under 15 years) and adult (aged 15
years and above) patients who were clinically diagnosed with dengue. All patients or their legal
guardians were invited to participate in the study and asked to sign an informed consent form.
Patients who did not give consent were excluded from the study. The recruitment period was
from March to September in 2015 and overlapped with the peak season of dengue illness.
Research procedures
We adapted a patient questionnaire, which was successfully used in previous cost-of-illness
studies in several dengue endemic countries [17]. It was translated into and back-translated
from Thai by two researchers who were fluent in both languages, and the discrepancies were
resolved through discussion. The questionnaire was piloted on 10 patients and validated before
its administration. It collected information on the demographic and socio-economic charac-
teristics of the patients and other household members, the characteristics of dengue illness epi-
sodes, work and school absenteeism, health care service utilization, household health care
spending and coping strategies, care provided to the patients by household members, and
household income loss due to the dengue illness episode.
Data collection and management
Patients or their legal guardians were interviewed in-person after recovery from the illness by
six experienced public health officers, and each officer received a half-day one-on-one training
Household costs of hospitalized dengue
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about the study protocol. The interviews took place at the hospital, the patient’s workplace or
home, or any other place convenient for the patient. Each interview lasted about 30–45 min-
utes. Patients or their legal guardians were compensated for their time with a stipend in the
amount of 200 Thai Baht (THB) (US$5.8). We followed up with 5–10 patients by phone
because there was missing data or inconsistent information in the completed questionnaires.
Data were entered into a Microsoft Access Database (2015, Microsoft Corp, Redmond, WA)
and analyzed using SAS 9.4 (SAS Institute Inc., Cary, NC).
Analytical framework
The unit of analysis was a dengue case, defined as a documented acute febrile illness with a
clinical diagnosis of dengue at the time of hospital discharge. This study examined all hospital-
ized dengue cases regardless of disease severity.
Household expenditures on dengue include direct medical and non-medical costs and indi-
rect costs incurred by the household during the dengue illness episode. Direct medical costs
comprised all household out-of-pocket payments for medical services received by the patient
prior to and during hospitalization. Direct non-medical costs included out-of-pocket pay-
ments for transportation, food and lodging for the patient and accompanying household
members while seeking and receiving medical care for the illness episode. Indirect costs
incurred by the household were assessed as the sum of lost paid work by the patient and other
household members aged 15 years and above while caring for the patient during the dengue ill-
ness episode. We valued lost paid work as the higher of the reported income loss or the esti-
mated income loss calculated conservatively as the product of the minimum daily wage (300
THB [38]) in Thailand times the number of reported workdays lost by the patient or other
household members. The value of time forgone from leisure or other non-market activities
was not included in the calculation of indirect costs. If reimbursements were paid to the house-
hold by health and/or income protection insurance, the amount reported was subtracted from
the sum of the direct and indirect costs for that particular household to arrive at a total cost
per case. We also reported on the number of school days lost by the patient and other house-
hold members due to dengue illness, as well as the total number of days household members
cared for the patient during the illness episode. All costs were presented as mean (± standard
deviation, SD) and expressed in 2015 US$ based on 34.2 THB to 1US$ currency exchange rate
[39].
Ethics statement
The protocol for this study was reviewed and approved by the Ethical Review Boards of Mahi-
dol University, Heidelberg University, Chachoengsao Provincial Public Health Office, and
Buddhasothorn Hospital. Signed informed consent was obtained from all patients or their
legal guardians. Participant information, such as gender, age, clinical diagnostic status and
contact information, was obtained from the hospital records. All the data collected through the
cost of illness questionnaire and the hospital records were analyzed anonymously.
Results
Characteristics of the study population and dengue illness episodes
A total of 570 hospitalized patients, who were clinically diagnosed with dengue, were eligible
to participate in the study. Of these hospitalized patients, 224 were recruited into the study.
The general characteristics of hospitalized dengue patients and dengue illness episodes are
summarized in Tables 1 and 2. Overall, 48% were female, and 24% were aged under 15 years of
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age. The age distribution of the study population is presented in Fig 1. The mean household
size was 4.4 persons (SD 1.9). Among adult hospitalized patients, 18% had primary school
education or less, 36% secondary school education, and 46% vocational/high school/college
education or above. Of the 224 hospitalized patients, 168 (75%) and 56 (25%) had a clinical
diagnosis of Dengue Fever (DF) and Dengue Hemorrhagic Fever (DHF), respectively, at the
time of hospital discharge. About 73% of DF patients and 86% of DHF patients were aged 15
years or above. There were no deaths in this cohort of hospitalized dengue patients.
Overall, hospitalized dengue patients reported 9.5 days (SD 3.4) of illness, including 3.8
days (SD 2.2) during which the patient felt bad or very bad. The mean duration of illness was
8.0 days (SD 2.1) for pediatric DF patients and 10.0 days (SD 2.9) for pediatric DHF patients,
including 4.3 days (SD 2.6) and 2.5 days (SD 0.8) during which the patient felt bad or very bad,
respectively. Adult DF and DHF patients, respectively, reported 9.5 days (SD 2.5) and 10.5
days (SD 4.8) of illness, including 3.5 days (SD 2.1) and 4.5 days (SD 2.2) during which the
patient felt bad or very bad.
Utilization of health care services
Forty-seven percent of caretakers reported seeking care for their children within 24 hours of
onset of illness, 15% reported seeking care one to two days after onset of illness, and 36%
waited more than two days. Thirty-six percent adult patients sought care within 24 hours after
Table 1. General characteristics of the hospitalized dengue patients, Chacheongsao province, Thai-
land, 2015.
Sex, n (%)
Male 117 (52)
Female 107 (48)
Age distribution, n (%)
<15 years 53 (24)
15 years 171 (76)
Highest level of education among adult patients, %
Primary school or less 18
Secondary school 34
Vocational school or more 45
Missing 3
Highest level of education in household with pediatric patients, %
Primary school or less 27
Secondary school 18
Vocational/high school, college or more 49
Missing 6
Patients currently studying, n (%)
53 patients < 15 years of age 48 (91)
171 patients15 years of age 43 (25)
Patients currently working, n (%)
53 patients <15 years of age 2 (4)
171 patients15 year of age 97 (57)
Household members currently studying, n (%)
602 household members 106 (17)
Household members currently working, n (%)
602 household members 312 (52)
https://doi.org/10.1371/journal.pntd.0005961.t001
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onset of illness, 27% sought care one to two days after onset of illness, and the remaining 35%
waited more than two days. Table 3 presents the type of health facility visited and the type of
health provider consulted by hospitalized dengue patients during their illness episode. Fifty-
four percent of the patients sought care at a hospital first and got hospitalized during their first
visit, followed by 15% visiting a doctor’s office and 14% a pharmacy. Sixty-eight percent of the
Table 2. General characteristics of the hospitalized dengue cases by patient age group and disease
severity, Chacheongsao province, Thailand, 2015.
Patient age group
<15 years 15 years All
Dengue diagnosis at hospital discharge, n (%)
DF 45 (85) 123 (72) 168 (75)
DHF 8 (15) 48 (28) 56 (25)
All 53 (100) 171 (100) 224 (100)
Duration of illness (days), mean±SD
DF 8.0±2.1 9.5±2.5 9.0±2.5
DHF 10.0±2.9 10.5±4.8 10.5±4.6
All 8.3±2.3 9.9±3.6 9.5±3.4
Patient feeling bad or very bad (days), mean±SD
DF 4.3±2.6 3.5±2.1 3.7±2.2
DHF 2.5±0.8 4.5±2.2 4.3±2.2
All 4.0±2.5 3.8±2.2 3.8±2.2
Time between onset of illness and seeking first treatment, n (%)
<24 hours 25 (48) 61 (37) 86 (39)
24–48 hours 8 (15) 47 (28) 55 (25)
>48 hours 19 (37) 59 (35) 78 (36)
Duration of hospital stay (nights), mean±SD
DF 4.0±2.6 3.7± 1.5 3.8±1.9
DHF 4.6±1.3 4.2±2.1 4.3±2.0
All 4.1±2.5 3.8±1.7 3.9±1.9
https://doi.org/10.1371/journal.pntd.0005961.t002
Fig 1. The age distribution of hospitalized dengue patients, Chacheongsao province, Thailand, 2015.
https://doi.org/10.1371/journal.pntd.0005961.g001
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first visits occurred in a public health facility. About 51% and 17% of the patients reported a
second and a third visit, respectively, where 64% and 84% of these visits resulted in hospitaliza-
tion, and 82% and 97% of them occurred in public health facilities. Two patients had multiple
hospitalizations during their illness episode.
Dengue patients spent, on average, 3.9 (SD 1.9) nights in the hospital. While the mean num-
ber of hospital nights for pediatric DF and DHF patients was 4.0 (SD 2.6) and 4.6 (SD 1.3),
respectively, adult DF and DHF patients spent, on average, 3.7 (SD 1.5) and 4.2 (SD 2.1) nights
in the hospital, respectively. None of the hospitalized dengue patients reported receiving care
in the intensive care unit.
Dengue illness affected school attendance and productive activities of the patients and
other household members. Table 4 presents the mean number of school days missed and work
days lost. Of the 91 hospitalized dengue patients who were studying at the time of illness, 79
reported missing school with an average of 6.8 (SD 4.0) days. Of the 53 pediatric dengue
patients, 48 were in school at the time of illness, and 45 missed an average of 6.5 (SD 3.8) days
of school. The mean number of school days missed was 6.6 (SD 3.9) and 6.1 (SD 3.1) days for
pediatric DF and DHF patients, respectively. Of the 171 hospitalized adult patients, 43 were in
school at the time of illness, and 34 reported missing school with an average of 7.2 (SD 4.2)
days. Of the 99 hospitalized dengue patients who were working for pay at the time of illness, 97
were adult patients, and 94 lost an average of 6.9 (SD 3.5) days of work due to the illness epi-
sode. The mean number of work days lost for adult DF and DHF patients was 6.6 (SD 3.6) and
7.6 (SD 3.1) days, respectively. The burden of a hospitalized dengue case on household mem-
bers was also considerable. Of the 602 household members, 52% and 17% reported to be
Table 3. Type of health facilities visited and health providers consulted by hospitalized dengue patients, Chacheongsao province, Thailand, 2015.
First visit Second visit Third visit Fourth visit Fifth visit
Type of health facility, n (%)
Hospital 120 (54) 73 (64) 32 (84) 2 (50) 2 (100)
Emergency care 6 (3) 7 (6) 1 (3) 0 (0) 0 (0)
Outpatient department at a hospital 13 (6) 13 (11) 4 (10) 2 (50) 0 (0)
Health center 20 (9) 3 (3) 0 (0) 0 (0) 0 (0)
Doctor’s office 34 (15) 13 (11) 0 (0) 0 (0) 0 (0)
Laboratory 0 (0) 1 (1) 1 (3) 0 (0) 0 (0)
Pharmacy 31 (14) 4 (4) 0 (0) 0 (0) 0 (0)
Type of health provider, n (%)
Public provider 152 (68) 93 (82) 37 (97) 4 (100) 2 (100)
Private provider 68 (30) 20 (18) 1 (3) 0 (0) 0 (0)
Don’t know 4 (2) 1 (0) 0 (0) 0 (0) 0 (0)
https://doi.org/10.1371/journal.pntd.0005961.t003
Table 4. Impact of a hospitalized dengue case on patients’ school attendance and productive activi-
ties, Chacheongsao province, Thailand, 2015.
Pediatric patients (<15 years) Adult patients (15 years) All
Days of school missed, mean±SD
DF 6.6±3.9 5.9±2.7 6.3±3.5
DHF 6.1±3.1 10.3±5.7 8.6±5.1
All 6.5±3.8 7.2±4.2 6.8±4.0
Days of work lost, mean±SD
DF 7.0±2.8 6.6±3.6 6.6±3.6
DHF - 7.6±3.1 7.6±3.1
All 7.0±2.8 6.9±3.5 6.9±3.5
https://doi.org/10.1371/journal.pntd.0005961.t004
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working and attending school, respectively. On average, household members missed 1.2 (SD
2.9) days of school and lost 4.1 (SD 3.9) days of work. The mean total number of days cared for
the patient during the illness episode was 7.2 (SD 4.9) per household.
Household costs of a hospitalized dengue case
Table 5 presents the direct, indirect and total costs of hospitalized dengue cases to households
by patient age category and disease severity. The mean total household cost of a hospitalized
pediatric and adult dengue case was US$155.4 (SD 112.1) and US$186.8 (SD 184.7), including
a mean reimbursement of US$7.7 (SD 24.1) and US$20 (SD 138.9), respectively. The direct
costs for pediatric and adult patients amounted to US$81.9 (SD 76.5) and US$109.3 (SD
190.4), constituting 52% and 59% of the total household costs while the mean indirect costs
were US$81.1 (SD 66.3) and US$97.5 (SD 110.3), respectively. The direct non-medical costs
accounted for the majority of the direct costs to households regardless of patient age category,
and were US$67.2 (SD 66.4) and US$78.6 (SD 94.7), constituting 82% and 72% of the direct
costs, respectively, the rest being the direct medical costs.
Overall, the total household cost of a hospitalized dengue case increased with disease sever-
ity. The mean total cost of a pediatric DF and DHF case to households was US$153.6 (SD
115.3) and US$166.3 (SD 96.3), respectively. Adult patients reported a mean household cost of
US$171.2 (SD 167.2) and US$226.1 (SD 220.1) for a DF and DHF case, respectively. The direct
non-medical costs similarly accounted for the majority of the direct costs to households
regardless of dengue disease severity. Among adult hospitalized patients, the direct medical
costs and the indirect costs were notably higher for DHF cases compared to DF cases.
Overall, 74% of the households reported that the patient received free medical care during
their illness episode, and 62% reported that the patient was covered by the Thai Universal
Coverage Scheme for health care. A great majority of the households (94%) reported not bor-
rowing money from outside the household or selling or transfering any household assets to
finance the dengue illness episode. About 27% reported using household savings, and 41%
reported that other household members helped finance the dengue illness episode.
Discussion
This was a prospective cost-of-illness study, which aimed to quantify the direct, indirect and
total costs of hospitalized dengue cases to patients and their households in a highly endemic,
Table 5. Household costs of hospitalized dengue illness by patient age group and disease severity,
Chacheongsao province, Thailand, 2015. All costs are reported in 2015 US$.
DF DHF All
Pediatric patients (<15 years), mean±SD
Direct cost 80.0±76.3 94.1±82.6 81.9±76.5
Medical cost 15.8±25.7 8.3±10.7 14.7±24.3
Non-medical cost 64.2±63.8 85.9±84.4 67.2±66.4
Indirect cost 81.7±68.7 77.7±53.5 81.1±66.3
Total cost 153.6±115.3 166.3±96.3 155.4±112.1
Adult patients ( 15 years), mean±SD
Direct cost 96.5±127.1 141.6±294.6 109.3±190.4
Medical cost 20.0±52.0 57.6±246.8 30.7±138.8
Non-medical cost 76.5±99.8 84.0±81.3 78.6±94.7
Indirect cost 84.7±80.1 129.8±160.2 97.5±110.3
Total cost 171.2±167.2 226.1±220.1 186.8±184.7
https://doi.org/10.1371/journal.pntd.0005961.t005
Household costs of hospitalized dengue
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0005961 September 22, 2017 8 / 13
semi-rural area in eastern Thailand. Overall, wide regional variations in dengue incidence
occur annually in Thailand [29]. During the period from 2014 to 2016, dengue-related mor-
bidity and mortality rates in Eastern region where Chacheongsao province is located were
notably higher than the national rates [40]. In the study year of 2015, dengue morbidity and
mortality rates were 328.7 and 0.6 per 100,000 population for the Eastern region, compared to
the national rates of 222.6 and 0.23 per 100,000 population, respectively [41]. While most pub-
lished cost-of-illness studies on dengue have focused on pediatric patients, this study included
adult patients in view of the recent shift in the mean age of dengue cases reported in Thailand
and other endemic countries in Southeast Asia.
The average household cost of a hospitalized dengue case in Chachoengsao province was
US$153.6–166.3 and US$171.2–226.1 for pediatric and adult patients, respectively. These costs
fell within the range of those reported in other studies for Thailand, ranging from US$44 in
2001 [42] to US$118 in 1994 [43], and for adult patients from US$138 to US$162 in 1994
(unadjusted costs) [43]. Overall, the total cost of a hospitalized dengue case to the household
was higher for adult patients than pediatric patients. Unsurprisingly, the severity of dengue ill-
ness was found to increase the financial burden on households due to more prolonged and
complicated treatment and longer illness period.
The direct medical costs constituted only a small portion of the direct costs and the total
costs, and were US$14.7 for pediatric patients and US$30.7 for adult patients. This could be
explained by the fact that the majority of the study population was covered by the Thai Univer-
sal Coverage Scheme for health care and paid THB30 (US$ 0.88) per visit or admission. This
co-pay was waived for children and elderly and for households with income less than
THB2,800 (US$81.9) per month. The direct non-medical costs increased with the severity of
dengue illness for both pediatric and adult patients. Our findings showed that the indirect
costs were as significant as the direct costs, constituting about half of the total costs to the
households. The indirect costs reported for pediatric patients in this study were similar to
those reported by other studies, ranging from US$20 in Khamphaeng Phet in 2001 to US$42
and US$51 for clinically diagnosed and laboratory confirmed dengue, respectively, in Khon
Kaen in 2005 (unadjusted costs) [44].
The average monthly household income in Chacheongsao province was THB27,555 (US
$806) in 2015 [45]. Our findings showed that a hospitalized dengue episode cost approximately
19–23% of the monthly household income, which was lower than what was previously
reported for Thailand as 37% [42]. However, some households had to use additional financial
sources, such as household savings (27%), or sought financial assistance from other household
members (41%) to finance the dengue illness episode. These coping strategies that deal with
direct costs of illness can potentially undermine future income streams and threaten the eco-
nomic sustainability of households. Our study potentially underestimated the total costs of
dengue illness to households because dengue episodes tend to cluster at the household level,
affecting multiple household members simultaneously. An earlier study in Thailand found
that dengue affected an average of 1.4 family members per household per episode [42].
There were several limitations to this study. It was conducted in three hospitals in a single
province with a focus on hospitalized clinically diagnosed dengue cases in the public health
sector. Previous cost of illness studies did not find any significant differences in health seeking
behavior and overall costs between laboratory confirmed and clinically diagnosed dengue
cases, and laboratory confirmed dengue and non-dengue febrile cases [34,46]. The total cost of
a hospitalized dengue case to a household is, however, expected to vary depending on the type
of hospital where care is received and whether the hospital is public or private. Similar to other
cost of illness studies, this study relied on self-reported costs, which are prone to recall bias. It
has been shown that a recall timeframe of one year is appropriate for rarely used health care
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services, such as hospitalization, and much shorter timeframes are recommended for more fre-
quently used services, such as doctor visits [47]. To minimize potential recall bias, patients were
contacted within one to six weeks of hospital discharge to check up on patient recovery progress
and set up an interview date, and were interviewed about within four to ten weeks of recovery.
The issue of self-reported costs is particularly important when considering the indirect costs
associated with an illness episode. The method of asking patients how many days they could not
work has been shown to overestimate the productivity losses from a disease [48]. This is mainly
because patients, particularly in low and middle income countries, would not have been work-
ing for all of those days in the absence of a disease. It is also a common coping strategy that
other household members fill in for a sick person or for a parent caring for a sick child to sustain
the household productivity [48]. We, therefore, estimated the value of lost paid work conserva-
tively using Thailand’s minimum daily wage when the patient or household member reported
number of work days lost rather than income loss. Despite these limitations, our study has the
most comprehensive cost-of-illness data for hospitalized dengue cases in Thailand to date.
The costs of inpatient care services absorbed by the government through the Thai Universal
Coverage scheme is beyond the scope of this study. We, however, received the hospital bills of
89 patients from the provincial hospital. The hospital bills indicated the length of hospital stay
and the service fees for inpatient care provided during hospitalization for each dengue patient.
The mean inpatient service fees for DF and DHF cases in the provincial hospital were US
$145.7 (SD 78.9) and US$152.1 (SD 107.1) for pediatric patients and US$132.2 (SD 62.5) and
US$144.9 (SD 82.3) for adult patients, respectively. The service fees are negotiated fees paid to
hospitals by the public health insurance. Therefore, they do not cover the full economic cost of
inpatient care provided at hospitals and are not comparable to the direct medical costs of hos-
pitalized dengue cases reported in other costing studies. Still, these service fees are relatively
high compared to the estimated direct medical costs of hospitalized DF and DHF cases at sec-
ondary care hospitals in Colombo district, Sri Lanka: US$ 51 (SD 1) and US$129 (SD 3) for
pediatric patients and US$32 (SD 1) and US$91 (SD 2) for adult patients (2012 US$), respec-
tively [22].
Conclusions
This study showed that dengue related illness imposes financial hardship on households in
Thailand when hospitalization is required. Although direct medical costs were covered for a
majority of hospitalized patients by the Thai Universal Coverage Scheme for health care, direct
non-medical and indirect costs were of great economic significance to households. These hid-
den costs of dengue illness are likely to increase given the shift in the mean age and severity of
dengue cases in Thailand and other dengue affected countries in the region. This begets the
question of whether households can be protected from these hidden costs through innovative
policy measures in dengue endemic countries. To fully understand the economic impact of
dengue illness on households, it is necessary to collect cost of illness data for both hospitalized
and non-hospitalized dengue cases and in both the public and private health sectors. The total
cost of a hospitalized dengue case in public facilities accounted for about 19–23% the monthly
household income. High household costs of dengue illness strongly justify efforts to improve
the coverage of preventive and control measures against dengue. Such cost of illness data are
also key to evaluating the cost-effectiveness of these measures, including dengue vaccines.
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